by Walter and Eliza Hall Institute of Medical Research The anti-cancer medicine venetoclax could improve the current therapy for estrogen receptor-positive (ER+) breast cancer—the most common form of breast cancer in Australia—according to preclinical studies led by Walter and Eliza Hall Institute researchers. The research team showed that venetoclax could kill breast cancer cells that...
by Karolinska Institutet Researchers at Karolinska Institutet in Sweden and the University of North Carolina in the USA have mapped out the cell types behind various brain disorders. The findings are published in Nature Genetics and offer a roadmap for the development of new therapies to target neurological and psychiatric disorders. One interesting finding was...
BY YEKATERINA KADYSHEVSKAYA, USC The discovery comes just as new data are revealing that some of the hardest hit victims of COVID-19 suffer from obesity and other chronic conditions A USC-led international team of scientists has found the precise shape of a key player in human metabolism, which could lead the way to better treatments...
Researchers at the University of Arizona’s College of Medicine — Tucson have teamed with scientists at two other institutions to identify the cause of post-brain injury headaches and uncover a potential new therapy for millions of patients UNIVERSITY OF ARIZONA HEALTH SCIENCES TUCSON, Ariz. – As she jumped to head a soccer ball during her...
by Elisabeth Reitman, Yale University The American Heart Association estimates that the total cost of heart failure in the United States could reach $70 billion by 2030. Volume overload contributes to 90% of heart failure-related hospitalizations in the U.S. A new therapy developed by Sequana Medical demonstrates that direct sodium removal (DSR) is a safer...
